Craig D. Gordon
Gordonmd Global Investments Lp
Assets Managed
$143.593M
Holdings
16
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
2.94%(2Q avg: 1.47%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Gordonmd Global Investments Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 16 positions.
Assets under management
The assets under management (AUM) of Gordonmd Global Investments Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 143.593M in assets, with a quarterly growth rate of 2.94% and a 2-quarter average growth rate of 1.47%. The portfolio is managed by Craig D. Gordon, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
KYTX Kyverna Therapeutics Inc
| 25.52% | $36.633M 4.245M shares@ $8.63 avg price | Decreased -3.34% |
TSHA Taysha Gene Therapies Inc
| 15.48% | $22.215M 737,550 shares@ $30.12 avg price | Decreased -44.58% |
VIR Vir Biotechnology Inc
| 9.48% | $13.606M 1.519M shares@ $8.97 avg price | Increased 63.23% |
BLCO Bausch + Lomb Corp
| 6.36% | $9.118M 573,472 shares@ $15.91 avg price | Decreased -6.52% |
AMGN Amgen Inc
| 4.96% | $7.112M 20,212 shares@ $351.85 avg price | Decreased -12.92% |
SRRK Scholar Rock Holding Corp
| 4.54% | $6.514M 132,500 shares@ $49.16 avg price | New Position |
RARE Ultragenyx Pharmaceutical In
| 4.22% | $6.057M 289,101 shares@ $20.96 avg price | Decreased -12.15% |
PYXS Pyxis Oncology Inc
| 4.2% | $6.018M 4.122M shares@ $1.46 avg price | |
TEVA Teva Pharmaceutical-sp Adr
| 3.92% | $5.621M 1.257M shares@ $4.48 avg price | Increased 63.41% |
SION Sionna Therapeutics Inc
| 3.8% | $5.452M 136,000 shares@ $40.09 avg price | New Position |
1-10 of 16